Identifiable biomarker and treatment development using HIV-1 long term non-progressor sera. - Wikidata - awgldk - TriplyDB

Identifiable biomarker and treatment development using HIV-1 long term non-progressor sera.

Identifiable biomarker and treatment development using HIV-1 long term non-progressor sera.

http://www.wikidata.org/entity/Q35540731

about

Identifiable biomarker and treatment development using HIV-1 long term non-progressor sera.

http://www.wikidata.org/entity/Q35540731

description

2015 nî lūn-bûn

@nan

2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Identifiable biomarker and tre ...... long term non-progressor sera.

@ast

Identifiable biomarker and tre ...... long term non-progressor sera.

@en

type

label

Identifiable biomarker and tre ...... long term non-progressor sera.

@ast

Identifiable biomarker and tre ...... long term non-progressor sera.

@en

prefLabel

Identifiable biomarker and tre ...... long term non-progressor sera.

@ast

Identifiable biomarker and tre ...... long term non-progressor sera.

@en

P1433

Q35540731-796B464C-89F3-4D44-A90D-AF5A017CBCBB

P1476

Q35540731-1E5AA2FF-405A-48F8-906F-D103751241CA

P2093

Q35540731-03FB0C1E-656F-4272-B7ED-2C9F01E75345

Q35540731-1F56FE87-B3E0-4E72-A905-72C9C435CB9F

Q35540731-5A6D6357-4948-4C2F-A3AE-F37A9029F040

Q35540731-B5B1A277-C2FF-457B-A5A6-182C3641019C

Q35540731-B66150A6-A8EA-4E0F-A889-A11C3A19890C

Q35540731-DC4679EB-EB16-4223-BB3E-FA1EE82FEB84

Q35540731-DF0D02B1-D047-4CC5-A0B3-550E793A7E44

P2860

Q35540731-02CCD950-E9AF-42F9-919D-F2B2CE2707A8

Q35540731-050578C7-6641-4CF8-9BB8-54BE183EF067

Q35540731-08406828-32E3-451C-A7F0-8CB31255EC9B

Q35540731-094C82DC-7AF6-4B28-AD5B-4BE1EED1AE8D

Q35540731-0C99C5F3-851D-4C73-87B0-F77DDC976A56

Q35540731-194D4FCE-9588-4889-B008-84E0AEA7AD37

Q35540731-198CE270-93B6-4C68-9600-020DE1D51599

Q35540731-22B5C853-C7E6-4586-897C-277A6D09EE58

Q35540731-2B3D6299-A961-4FEF-9B76-1A1A08B59728

Q35540731-2C28FC46-6494-4BE8-8F31-4A4CCC2B79B2

P2888

Q35540731-76456F7E-C789-4828-82AF-919387F9C627

P304

Q35540731-64E5C15D-AA98-465B-8FBA-A3948EE07E0B

P31

Q35540731-68F57C79-B05F-4C50-B488-2FDC839D09D7

P356

Q35540731-7213990F-9C09-4809-A597-C783804AE1DD

P478

Q35540731-4D1060C4-1B84-4296-8FA1-8D3116CE5245

P577

Q35540731-9A46FAF2-A50E-46AC-A4E7-EB935A16F241

P5875

Q35540731-4A6E1B6D-B46F-42D5-8284-A7480C1DC3C2

P6179

Q35540731-24F2FC39-AFAC-4FAF-BED1-C88EB543E9BF

P698

Q35540731-6995D575-2DA4-4F57-9DEA-D4FF69F151B5

P921

Q35540731-FEC135C8-3CEB-4A57-B522-19C88962213F

P932

Q35540731-2FF5F716-0280-4F6B-929E-FE1E4EB47878

P356

S12865-015-0094-Z

P1433

P1476

Identifiable biomarker and tre ...... long term non-progressor sera.

@en

P2093

Chuanhai Cao

http://www.w3.org/2001/XMLSchema#string

Ge Bai

http://www.w3.org/2001/XMLSchema#string

Jianfeng Cai

http://www.w3.org/2001/XMLSchema#string

Junping Wang

http://www.w3.org/2001/XMLSchema#string

Kyle Sutherland

http://www.w3.org/2001/XMLSchema#string

Longfeng Zhao

http://www.w3.org/2001/XMLSchema#string

Yuxia Hao

http://www.w3.org/2001/XMLSchema#string

P2860

Additive Effects Characterize the Interaction of Antibodies Involved in Neutralization of the Primary Dualtropic Human Immunodeficiency Virus Type 1 Isolate 89.6

Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies

Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody

Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1

Soluble factors from T cells inhibiting X4 strains of HIV are a mixture of β chemokines and RNases.

Fine definition of the epitope on the gp41 glycoprotein of human immunodeficiency virus type 1 for the neutralizing monoclonal antibody 2F5.

Growth patterns in pubertal HIV-infected adolescents and their correlation with cytokines, IGF-1, IGFBP-1, and IGFBP-3.

Protection of Macaques against pathogenic simian/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodies.

Synergistic neutralization of simian-human immunodeficiency virus SHIV-vpu+ by triple and quadruple combinations of human monoclonal antibodies and high-titer anti-human immunodeficiency virus type 1 immunoglobulins.

Immunoreactivity of intact virions of human immunodeficiency virus type 1 (HIV-1) reveals the existence of fewer HIV-1 immunotypes than genotypes.

P2888

s12865-015-0094-z

P304

25

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12865-015-0094-Z

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P577

2015-04-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

275634310

http://www.w3.org/2001/XMLSchema#string

P6179

1010197861

http://www.w3.org/2001/XMLSchema#string

P698

25927639

http://www.w3.org/2001/XMLSchema#string

P921

P932

4410489

http://www.w3.org/2001/XMLSchema#string